Hangjun Zhan serves as Executive at Kindred Biosciences, Inc., where they oversee executive responsibilities. Since joining the company, Hangjun Zhan has executed 13 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Aug 27, 2021 involved selling 64,306 shares valued at $594.8K.
Hangjun Zhan currently holds 39,306 shares of Kindred Biosciences, Inc. (KIN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Hangjun Zhan has been a net neutral trader of KIN stock. They have purchased $0 and sold $0 worth of shares.
Hangjun Zhan's most recent insider trade was on Aug 27, 2021, when they sold 64,306 shares at $9.25 per share.
Get notified when new Form 4 filings are submitted
| $4.93 |
| Discretionary |
| Jan 22, 2021 | KIN | $0 | Option Exercise | 6,250 | $N/A | Discretionary |
| Jan 22, 2021 | KIN | $16.7K | Payment | 3,385 | $4.93 | Discretionary |
| Jan 17, 2021 | KIN | $16.8K | Payment | 3,385 | $4.95 | Discretionary |
| Jan 17, 2021 | KIN | $0 | Option Exercise | 6,250 | $N/A | Discretionary |
| Jan 23, 2020 | KIN | $20.6K | Payment | 2,128 | $9.66 | Discretionary |
| Jan 22, 2020 | KIN | $21.0K | Payment | 2,121 | $9.88 | Discretionary |
| Jan 22, 2020 | KIN | $0 | Option Exercise | 6,250 | $N/A | Discretionary |
| Jan 23, 2019 | KIN | $21.2K | Payment | 2,132 | $9.95 | Discretionary |
| Jan 22, 2019 | KIN | $0 | Option Exercise | 6,250 | $N/A | Discretionary |
| Jan 22, 2019 | KIN | $23.3K | Payment | 2,305 | $10.12 | Discretionary |
| Jan 23, 2018 | KIN | $17.0K | Payment | 1,853 | $9.15 | Discretionary |